James Dirk Inglehart

Title: James Dirk Inglehart: Innovator in Cancer Research

Introduction

James Dirk Inglehart is a prominent inventor based in Durham, NC (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, Inglehart's work focuses on the development of methods and oligonucleotides that have the potential to improve cancer detection and treatment.

Latest Patents

Inglehart's latest patents include groundbreaking inventions such as "Antisense oligonucleotides against ERBB-2." This patent describes oligonucleotides that consist of specific nucleotide sequences, which are useful for inhibiting the expression of the ERBB2 tyrosine kinase receptor in cells, both in vitro and in vivo. Another significant patent is the "Method of detecting tumors containing complexes of p53 and HSP70." This invention relates to the identification of mutant p53 proteins that bind to HSP70, which can help classify tumor cells and monitor patients for disease recurrence.

Career Highlights

James Dirk Inglehart is affiliated with Duke University, where he conducts research and collaborates with other experts in the field. His work has been instrumental in advancing the understanding of cancer biology and developing new diagnostic methods.

Collaborations

Inglehart has worked alongside notable colleagues such as Jeffrey R Marks and Andrew Mark Davidoff. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

James Dirk Inglehart is a distinguished inventor whose contributions to cancer research are noteworthy. His patents reflect a commitment to improving cancer detection and treatment methodologies. Through his work at Duke University and collaborations with esteemed colleagues, Inglehart continues to make a significant impact in the field of medical research.